Skip to content

Clinical trials

Completed Phase 1/2 Multiple Sclerosis, Relapsing-Remitting trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis, Relapsing-Remitting Phase: Phase 1/2 Status: Completed Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20071
20101
20121
20131
20141
20151
20171
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abu Dhabi Stem Cells Center1
Banc de Sang i Teixits1
Charite University, Berlin, Germany1
Germans Trias i Pujol Hospital1
Johns Hopkins University1
Mapi Pharma Ltd.1
Opexa Therapeutics, Inc.1
Universidad Austral de Chile1
Universitätsklinikum Hamburg-Eppendorf1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis, Relapsing-Remitting9
Multiple Sclerosis5
Multiple Sclerosis, Chronic Progressive4
Nervous System Diseases2
Autoimmune Diseases1
Demyelinating Diseases1
Inflammation1
Nerve Degeneration1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.